FR2224140A1 - Polyvinyl pyrrolidone veterinary compns - for internal or external treatment of gastrointestinal inflammatory and gynaecological conditions - Google Patents
Polyvinyl pyrrolidone veterinary compns - for internal or external treatment of gastrointestinal inflammatory and gynaecological conditionsInfo
- Publication number
- FR2224140A1 FR2224140A1 FR7312255A FR7312255A FR2224140A1 FR 2224140 A1 FR2224140 A1 FR 2224140A1 FR 7312255 A FR7312255 A FR 7312255A FR 7312255 A FR7312255 A FR 7312255A FR 2224140 A1 FR2224140 A1 FR 2224140A1
- Authority
- FR
- France
- Prior art keywords
- veterinary
- compns
- internal
- polyvinyl pyrrolidone
- external treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
- A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
- A61K31/79—Polymers of vinyl pyrrolidone
Abstract
Therapeutic compsns. comprising as active component polyvinylpolyprrolidone (I) optionally together with coccidiostats, sulphonamides, antiseptics, antibiotics, adsorbents and vitamines are useful in veterinary treatment of gastrointestinal, inflammatory and gynaecological conditions, internally or externally; (I) are insoluble in acids and alkalis, non-allergic and non-toxic, and adsorb toxins in their three-dimensional network allowing tissues to regenerate.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7312255A FR2224140A1 (en) | 1973-04-05 | 1973-04-05 | Polyvinyl pyrrolidone veterinary compns - for internal or external treatment of gastrointestinal inflammatory and gynaecological conditions |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7312255A FR2224140A1 (en) | 1973-04-05 | 1973-04-05 | Polyvinyl pyrrolidone veterinary compns - for internal or external treatment of gastrointestinal inflammatory and gynaecological conditions |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2224140A1 true FR2224140A1 (en) | 1974-10-31 |
FR2224140B1 FR2224140B1 (en) | 1976-04-09 |
Family
ID=9117453
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7312255A Granted FR2224140A1 (en) | 1973-04-05 | 1973-04-05 | Polyvinyl pyrrolidone veterinary compns - for internal or external treatment of gastrointestinal inflammatory and gynaecological conditions |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR2224140A1 (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2414917A1 (en) * | 1978-01-24 | 1979-08-17 | Schiapparelli Spa | Syrups contg. gentamycin and kaolin - for gastrointestinal infections, stabilised by reducing the metal content of the kaolin |
US4210633A (en) * | 1978-10-20 | 1980-07-01 | Eli Lilly And Company | Flurandrenolide film formulation |
EP0035142A2 (en) * | 1980-02-22 | 1981-09-09 | BASF Aktiengesellschaft | Utilisation of micronized, crosslinked insoluble polyvinylpyrrolidone for the stabilisation of suspensions |
US4289749A (en) * | 1979-08-14 | 1981-09-15 | Key Pharmaceuticals, Inc. | Polymeric diffusion matrix containing phenylpropanolamine |
US4291014A (en) * | 1979-01-11 | 1981-09-22 | Key Pharmaceuticals, Inc. | Polymeric diffusion matrix containing estradiol diacetate |
EP2186521A1 (en) * | 2008-11-14 | 2010-05-19 | Mergemeier Steffen | Compositons for the treatment and prevention of diseases involving bacterial, viral and fungal pathogens and fragments thereof with polyvinylpyrrolidone and/or polyvinylpolypyrrolidone as therapeutically active compound |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4906475A (en) | 1988-02-16 | 1990-03-06 | Paco Pharmaceutical Services | Estradiol transdermal delivery system |
-
1973
- 1973-04-05 FR FR7312255A patent/FR2224140A1/en active Granted
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2414917A1 (en) * | 1978-01-24 | 1979-08-17 | Schiapparelli Spa | Syrups contg. gentamycin and kaolin - for gastrointestinal infections, stabilised by reducing the metal content of the kaolin |
US4210633A (en) * | 1978-10-20 | 1980-07-01 | Eli Lilly And Company | Flurandrenolide film formulation |
US4291014A (en) * | 1979-01-11 | 1981-09-22 | Key Pharmaceuticals, Inc. | Polymeric diffusion matrix containing estradiol diacetate |
US4292303A (en) * | 1979-08-14 | 1981-09-29 | Key Pharmaceuticals, Inc. | Polymeric diffusion matrix containing clonidine |
US4289749A (en) * | 1979-08-14 | 1981-09-15 | Key Pharmaceuticals, Inc. | Polymeric diffusion matrix containing phenylpropanolamine |
US4291015A (en) * | 1979-08-14 | 1981-09-22 | Key Pharmaceuticals, Inc. | Polymeric diffusion matrix containing a vasodilator |
US4292302A (en) * | 1979-08-14 | 1981-09-29 | Key Pharmaceuticals, Inc. | Polymeric diffusion matrix containing terbutaline |
US4292301A (en) * | 1979-08-14 | 1981-09-29 | Key Pharmaceuticals, Inc. | Polymeric diffusion matrix containing ephedrine |
US4294820A (en) * | 1979-08-14 | 1981-10-13 | Key Pharmaceuticals, Inc. | Polymeric diffusion matrix containing phenylephrine |
EP0035142A2 (en) * | 1980-02-22 | 1981-09-09 | BASF Aktiengesellschaft | Utilisation of micronized, crosslinked insoluble polyvinylpyrrolidone for the stabilisation of suspensions |
EP0035142A3 (en) * | 1980-02-22 | 1982-06-23 | BASF Aktiengesellschaft | Utilisation of micronized, crosslinked insoluble polyvinylpyrrolidone for the stabilisation of suspensions |
EP2186521A1 (en) * | 2008-11-14 | 2010-05-19 | Mergemeier Steffen | Compositons for the treatment and prevention of diseases involving bacterial, viral and fungal pathogens and fragments thereof with polyvinylpyrrolidone and/or polyvinylpolypyrrolidone as therapeutically active compound |
WO2010054858A2 (en) * | 2008-11-14 | 2010-05-20 | Steffen Mergemeier | Polyvinylpyrrolidone as a therapeutically active compound for the treatment and prevention of diseases involving bacterial, viral and fungal pathogens |
WO2010054858A3 (en) * | 2008-11-14 | 2010-08-19 | Steffen Mergemeier | Polyvinylpyrrolidone as a therapeutically active compound for the treatment and prevention of diseases involving bacterial, viral and fungal pathogens |
Also Published As
Publication number | Publication date |
---|---|
FR2224140B1 (en) | 1976-04-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA942894A (en) | Patient treatment table | |
EP0142426A3 (en) | Ophthalmic formulation containing norfloxacin and related antibiotics | |
ES2151607T3 (en) | GROWTH AND DIFFERENTIATION FACTOR 12. | |
FR2224140A1 (en) | Polyvinyl pyrrolidone veterinary compns - for internal or external treatment of gastrointestinal inflammatory and gynaecological conditions | |
IE40860B1 (en) | Substituted benzamides | |
SE9201930D0 (en) | GASTRIC ANTIBACTERIAL TREATMENT | |
IL39212A0 (en) | N-(dimethylaminomethylidene)-thiol and-thiono-phosphoric acid ester imides,their preparation and their use as insecticides or acaricides | |
AU462701B2 (en) | Polymer biologically active protein complexes | |
FR2282903A1 (en) | TRIACYL ESTERS IN 9.3 '', 4 '' POSITIONS OF THE SF-837 M1 ANTIBIOTIC AND ASSOCIATED PREPARATION PROCESS | |
CA931666A (en) | Patient treatment table | |
SE7908636L (en) | USE OF SALINOMYCIN AS AN EFFECTIVE SUBSTANCE TO IMPROVE NUTRITION AND ADMINISTRATION OF RUMINATORS AND ANIMAL SPECIES WITH SIMILAR DIGESTION PHYSIOLOGY | |
AU454611B2 (en) | Thienyl-fattyacid derivatives processes for their production, and their use as therapeutic agents | |
AU471736B2 (en) | N-(aminomethylidene0-thiol-phosphoric acid ester imides, process for their manufacture and their use as insecticides and acaricides | |
IT956328B (en) | POROUS BODY RIGIDED AT THE EDGES PROCEDURE AND DEVICE FOR THE PRODUCTION OF THE SAME | |
AU4851072A (en) | Air supply manifold fora hydrotherapy treatment system | |
IE811449L (en) | Pyrrolidine derivatives. | |
CA1019122A (en) | Modacrylic filaments wet-spun from solution in three-stage coagulation | |
EP0058015A3 (en) | Treatment of infections | |
TR17151A (en) | DISUBSTITUEE N- (AMINOMETYLIDEN) -TIOL (TIONO) PHOSPHORIC ACID ESTER IMIDES, PROCEDURES SPECIFIC TO ITS PRODUCTS AND INSECTICIDES AND THEIR USE AS MISCIDES | |
SU628904A1 (en) | Anesthesia method | |
CA945163A (en) | Acryloyl-2 benzimidazoles, leur procede de preparation et leur application en therapeutique | |
CA989836A (en) | Substituted axazino (5,6,e) indole, its manufacturing process and therapeutic application | |
CA998679A (en) | Substituted benzimidazoles, their preparation and use | |
MX9710126A (en) | Substituted compounds with sulphonamide, process for its preparation, its use as a medicament or diagnostic agent as well as pharmaceutical preparations. | |
GB769331A (en) | Improvements in or relating to the storage of articles |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |